scholarly journals 1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial)

2004 ◽  
Vol 43 (5) ◽  
pp. A448
Author(s):  
Eva Gerdts ◽  
Vasilios Papademetriou ◽  
Kristian Wachtell ◽  
Markku Nieminen ◽  
Hans Bjornstad ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Left Ventricular Hypertrophy ◽  
Pulse Pressure ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Risk Marker ◽  
Hypertensive Patients ◽  
Cardiovascular Risk Marker

scholarly journals Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study

2004 ◽  
Vol 66 ◽  
pp. S56-S58 ◽  
Author(s):  
Hans Ibsen ◽  
Kristian Wachtell ◽  
Michael H. Olsen ◽  
Knut Borch-JohnseN ◽  
Lars H. Lindholm ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Hypertensive Patients ◽  
Life Study

24-HOUR PULSE PRESSURE AT HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S160
Author(s):  
I. S. Tasic ◽  
B. Lovic ◽  
V. Stefanovic ◽  
D. Djordjevic ◽  
S. Ilic ◽  
...  
Keyword(s):  
Left Ventricular Hypertrophy ◽  
Pulse Pressure ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Hypertensive Patients

scholarly journals Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

2011 ◽  
Vol 25 (12) ◽  
pp. 711-718 ◽  
Author(s):  
F Fyhrquist ◽  
K Silventoinen ◽  
O Saijonmaa ◽  
K Kontula ◽  
R B Devereux ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Left Ventricular Hypertrophy ◽  
Telomere Length ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Hypertensive Patients ◽  
Life Study
Sign in / Sign up

Export Citation Format

Share Document